Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Octapharma Ag patents (2015 archive)

Recent patent applications related to Octapharma Ag. Octapharma Ag is listed as an Agent/Assignee. Note: Octapharma Ag may have other listings under different names/spellings. We're not affiliated with Octapharma Ag, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Octapharma Ag-related inventors

09/10/15 / #20150250879

Test for hemolytic potential of pharmaceutical products and formulations for risk minimization

A non-hemolytic acidic composition comprising an immunoglobulin selected from immunoglobulin a, immunoglobulin g or immunoglobulin m at a ph value in the range of 4.65 to 5.7 comprising one or more excipients selected from amino acids, sugars and sugar alcohols in a concentration range of 100-350 mmol/l, in particular 200-350 mmol/l, characterized in that it displays an optical density (od) in the range of 0.14 to −0.1 when the od is determined in a spectrophotometer at 414 nm at a film thickness of 0.825 mm; and its use in an assay for determination of the hemolytic potential of intravenously applied pharmaceuticals and compositions and preparations displaying a reduced potential of hemolysis when being applied intravenously.. . ... Octapharma Ag

07/09/15 / #20150190478

New protecting compositions for recombinantly produced factor vii

. . A histidine-free composition comprising: a high purity factor viii (r-factor viii); arginine and/or sucrose; a surface-active agent to prevent or at least inhibit surface adsorption of factor viii; an amount of calcium chloride for specific stabilization of factor viii.. . ... Octapharma Ag

02/12/15 / #20150045539

Process for production of fibrinogen and fibrinogen produced thereby

A process for purifying fibrinogen from a fibrinogen containing source by precipitation of fibrinogen by a precipitating agent from a fibrinogen containing solution in the presence of one or more chelating agent(s) and removal of the supernatant from the fibrinogen paste, characterised in that fibrinogen is extracted from the paste forming a liquid fraction containing fibrinogen, and an undissolved residue, which is separated from the liquid.. . ... Octapharma Ag

02/12/15 / #20150044720

Serum-free stable transfection and production of recombinant human proteins in human cell lines

The present invention relates to an improved method for the serum-free production of an immortalized human cell line stably transfected under serum-free conditions with a specific vector carrying the gene coding for the protein of interest. Furthermore the invention relates to a production cell line obtained by said method, a production method for said protein of interest utilizing said production cell line, and the specific vector carrying the gene of interest itself.. ... Octapharma Ag

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Octapharma Ag in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Octapharma Ag with additional patents listed. Browse our Agent directory for other possible listings. Page by